ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "TherapeuticsMD, Inc." (TXMD) Report Updated: Jul 21, 2014 | Print This Page

Get more stock ratings by Louis Navellier

"TherapeuticsMD, Inc." (TXMD)

Rating: Buy Volatility: Aggressive
Total Grade: B Industry: Pharmaceuticals
Competitors: PTIE, MRK, LCI, AKRX

Stock Analysis

Rating: Monthly View

A
B
C
D
F
July August September October November December January February March April May June

Rating: Weekly View

This Week: B down no change
Last Week: B same upgrade
Two Weeks Ago: C up no change
service keys

"TherapeuticsMD, Inc."© quotemedia

Company Profile

TherapeuticsMD, Inc. operates as a women’s healthcare product company in the United States. The company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter, vitamins, and cosmetics. It offers prenatal vitamins, vegan docosahexaenoic acid, iron supplements, Vitamin D supplements, natural menopause relief products, and scar tissue and cosmetic stretch mark creams under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy and pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal dryness. TherapeuticsMD markets its products primarily through a direct national sales force to healthcare providers, as well as directly through its Website to consumers. The company was founded in 2008 and is based in Boca Raton, Florida.

Recent News: "TherapeuticsMD, Inc."